<DOC>
	<DOCNO>NCT00192387</DOCNO>
	<brief_summary>The primary objective study determine proportion subject , seronegative three strain influenza , define serum hemagglutination inhibition antibody ( HAI ) antibody titer &lt; 1:10 , shed vaccine virus strain follow single dose CAIV-T .</brief_summary>
	<brief_title>Trial Investigate Viral Shedding Healthy Children Vaccinated With Vaccine Virus Liquid ( CAIV-T )</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>child least 6 month age less equal 18 month age time enrollment , good health determine medical history , physical examination , clinical judgment ; whose parent/legal guardian provide write informed consent nature study explain ; , along parent legal guardian , available two month duration trial ( enrollment study completion ) . whose parent legal guardian perceive unavailable difficult contact evaluation study visit study period ; serious chronic disease ( e.g. , sign cardiac renal failure severe malnutrition ) , include progressive neurological disease ; Down 's syndrome know cytogenetic disorder ; know suspected disease immune system receive immunosuppressive therapy , include systemic corticosteroid ; intranasal steroid cytotoxic agent ; immunosuppressed immunocompromised individual living household ; document history hypersensitivity egg egg protein component study vaccine placebo ; , anytime prior study enrollment , receive influenza vaccine ( commercial investigational ) ; medical condition opinion investigator might interfere interpretation study result . Note : A pregnant household member consider contraindication enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>December 2006</verification_date>
</DOC>